Ying Huang
Stock Analyst at B of A Securities
(1.39)
# 2,486
Out of 4,433 analysts
21
Total ratings
51.85%
Success rate
5.38%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $350 → $400 | $440.64 | -9.22% | 3 | Jul 21, 2023 | |
| RDUS Radius Health | Maintains: Buy | n/a | $19.05 | - | 1 | Jul 25, 2018 | |
| RGNX REGENXBIO | Downgrades: Neutral | n/a | $16.01 | - | 3 | Jul 23, 2018 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | n/a | $2.59 | - | 2 | May 2, 2018 | |
| CTMX CytomX Therapeutics | Maintains: Buy | n/a | $2.00 | - | 2 | Mar 8, 2018 | |
| BLUE bluebird bio | Maintains: Neutral | n/a | $1.05 | - | 1 | Feb 22, 2018 | |
| GILD Gilead Sciences | Maintains: Neutral | n/a | $67.86 | - | 2 | Feb 7, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | n/a | $4.41 | - | 2 | Jan 24, 2018 | |
| IRWD Ironwood Pharmaceuticals | Downgrades: Underperform | n/a | $6.64 | - | 1 | Jan 5, 2018 | |
| BIIB Biogen | Maintains: Buy | n/a | $230.04 | - | 1 | Oct 18, 2017 | |
| BOLD Boundless Bio | Maintains: Buy | n/a | $9.96 | - | 1 | Sep 22, 2017 | |
| ALRN Aileron Therapeutics | Initiates: Buy | n/a | $3.85 | - | 1 | Jul 24, 2017 | |
| AMGN Amgen | Upgrades: Buy | n/a | $314.72 | - | 1 | Feb 1, 2017 |
Vertex Pharmaceuticals
Jul 21, 2023
Maintains: Buy
Price Target: $350 → $400
Current: $440.64
Upside: -9.22%
Radius Health
Jul 25, 2018
Maintains: Buy
Price Target: n/a
Current: $19.05
Upside: -
REGENXBIO
Jul 23, 2018
Downgrades: Neutral
Price Target: n/a
Current: $16.01
Upside: -
Esperion Therapeutics
May 2, 2018
Downgrades: Underperform
Price Target: n/a
Current: $2.59
Upside: -
CytomX Therapeutics
Mar 8, 2018
Maintains: Buy
Price Target: n/a
Current: $2.00
Upside: -
bluebird bio
Feb 22, 2018
Maintains: Neutral
Price Target: n/a
Current: $1.05
Upside: -
Gilead Sciences
Feb 7, 2018
Maintains: Neutral
Price Target: n/a
Current: $67.86
Upside: -
Puma Biotechnology
Jan 24, 2018
Maintains: Buy
Price Target: n/a
Current: $4.41
Upside: -
Ironwood Pharmaceuticals
Jan 5, 2018
Downgrades: Underperform
Price Target: n/a
Current: $6.64
Upside: -
Biogen
Oct 18, 2017
Maintains: Buy
Price Target: n/a
Current: $230.04
Upside: -
Boundless Bio
Sep 22, 2017
Maintains: Buy
Price Target: n/a
Current: $9.96
Upside: -
Aileron Therapeutics
Jul 24, 2017
Initiates: Buy
Price Target: n/a
Current: $3.85
Upside: -
Amgen
Feb 1, 2017
Upgrades: Buy
Price Target: n/a
Current: $314.72
Upside: -